New drug tested to control painful blistering skin disease
NCT ID NCT04206553
Summary
This study tested whether an injectable drug called dupilumab is effective and safe for treating bullous pemphigoid, a serious autoimmune disease that causes severe blistering and itching, mostly in older adults. The trial involved 106 participants and compared dupilumab against a placebo. A key goal was to see if the drug could help patients achieve and maintain clear skin while also reducing or stopping the need for steroid pills.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BULLOUS PEMPHIGOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regeneron Study Site
Scottsdale, Arizona, 85259, United States
-
Regeneron Study Site
Redwood City, California, 94063, United States
-
Regeneron Study Site
Farmington, Connecticut, 06030, United States
-
Regeneron Study Site
Miami, Florida, 33125, United States
-
Regeneron Study Site
Iowa City, Iowa, 52242, United States
-
Regeneron Study Site
Boston, Massachusetts, 02116, United States
-
Regeneron Study Site
Chapel Hill, North Carolina, 27516, United States
-
Regeneron Study Site
Portland, Oregon, 97239, United States
-
Regeneron Study Site
Philadelphia, Pennsylvania, 19104, United States
-
Regeneron Study Site
Murray, Utah, 84107, United States
-
Regeneron Study Site
Kogarah, New South Wales, 2217, Australia
-
Regeneron Study Site
Box Hill, Victoria, 3128, Australia
-
Regeneron Study Site
Bobigny, 93009, France
-
Regeneron Study Site
Bordeaux, 33000, France
-
Regeneron Study Site
Lille, 59037, France
-
Regeneron Study Site
Nice, 06200, France
-
Regeneron Study Site
Paris, 75010, France
-
Regeneron Study Site
Rouen, 76031, France
-
Regeneron Study Site
Münster, North Rhine-Westphal, 48149, Germany
-
Regeneron Study Site
Mainz, Rhineland-Palatinate, 55131, Germany
-
Regeneron Study Site
Lübeck, Schleswig-Holstein, 23538, Germany
-
Regeneron Study Site
Berlin, 10117, Germany
-
Regeneron Study Site
Buxtehude, 21614, Germany
-
Regeneron Study Site
Erlangen, 91054, Germany
-
Regeneron Study Site
Freiburg im Breisgau, 79104, Germany
-
Regeneron Study Site
Munich, 80802, Germany
-
Regeneron Study Site
Stuttgart, 70178, Germany
-
Regeneron Study Site
Hirosaki, 036-8563, Japan
-
Regeneron Study Site
Ichinomiya, 491-8558, Japan
-
Regeneron Study Site
Osaka, 545-8586, Japan
-
Regeneron Study Site
Sapporo, 060-8648, Japan
-
Regeneron Study Site
Tokyo, 160-8582, Japan
-
Regeneron Study Site
Krakow, Lesser Poland Voivodeship, 31-147, Poland
-
Regeneron Study Site
Badalona, Barcelona, 08916, Spain
-
Regeneron Study Site
Madrid, 28034, Spain
-
Regeneron Study Site 2
Dresden, Saxony, 01307, Germany
-
Regeneron Study site
Marburg, 35043, Germany
-
Regeneron Study site
Kurume, Hukuoka, 830-0011, Japan
-
Regeneron Study site'
Magdeburg, 39120, Germany
-
Regeneron Study site'
Ossy, 42-624, Poland
-
Regeneron Study site'
Wroclaw, 50566, Poland
-
Regeneron study Site
Birmingham, Alabama, 35233, United States
-
Regeneron study Site
Orlando, Florida, 32827, United States
-
Regeneron study Site
Ann Arbor, Michigan, 48109-5314, United States
-
Regeneron study Site
Providence, Rhode Island, 02908, United States
-
Regeneron study Site
Charlottesville, Virginia, 22903, United States
-
Regeneron study Site
Afula, 1834111, Israel
-
Regeneron study Site
Petah Tikva, 49100, Israel
-
Regeneron study Site
Tel Aviv, 6423906, Israel
-
Regeneron study Site
Madrid, 28046, Spain
-
Regeneron study Site
Pamplona, 31008, Spain
-
Regeneron study Site
Taipei, Zhongzheng District, 10002, Taiwan
-
Regeneron study Site
Taoyuan, 33305, Taiwan
Conditions
Explore the condition pages connected to this study.